Safety and Efficacy of Ombitasvir, Paritaprevir With Ritonavir ± Dasabuvir With or Without Ribavirin in Patients With Human Immunodeficiency Virus-1 and Hepatitis C Virus Genotype 1 or Genotype 4 Coinfection: TURQUOISE-I Part 2. (Q41694415)
Jump to navigation
Jump to search
scientific article published on 22 July 2017
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Safety and Efficacy of Ombitasvir, Paritaprevir With Ritonavir ± Dasabuvir With or Without Ribavirin in Patients With Human Immunodeficiency Virus-1 and Hepatitis C Virus Genotype 1 or Genotype 4 Coinfection: TURQUOISE-I Part 2. |
scientific article published on 22 July 2017 |
Statements
1 reference
Safety and Efficacy of Ombitasvir, Paritaprevir With Ritonavir ± Dasabuvir With or Without Ribavirin in Patients With Human Immunodeficiency Virus-1 and Hepatitis C Virus Genotype 1 or Genotype 4 Coinfection: TURQUOISE-I Part 2. (English)
1 reference
Tami Pilot-Matias
1 reference
Adriano Lazzarin
1 reference
Anne F Luetkemeyer
1 reference
Chloe Orkin
1 reference
Jürgen K Rockstroh
1 reference
David Wyles
1 reference
Roger Trinh
1 reference
Linda M Fredrick
1 reference
Ruth Soto-Malave
1 reference
Sanjay R Bhagani
1 reference
Nancy S Shulman
1 reference
Pierre-Marie Girard
1 reference
Rolando M Viani
1 reference
Mark R Nelson
1 reference
Hartwig H F Klinker
1 reference
Giuliano Rizzardini
1 reference
Cristina Tural
1 reference
Niloufar Mobashery
1 reference
Yiran B Hu
1 reference
Edward Gane
1 reference
1 reference
23 July 2017
1 reference
Identifiers
1 reference